Leverage a partner with an extensive portfolio and accelerate your mRNA Process Development.
RNA therapies continue to challenge the central tenets of how to treat diseases; however, mRNA development and characterization are not always simple.
mRNA necessitates rigorous analytical validation at every processing step. Proper quality controls can ensure consistent synthesis and packaging into lipid nanoparticles, resulting in better therapeutic outcomes.
Analytical Solutions
Increase workflow reproducibility and standardization with cutting edge tools
Application Note
High-throughput characterization of RNA using the BioPhase 8800 system
Application Note
mRNA-LNP nucleic acid assessment from distinct formulations by multi-capillary gel electrophoresis
Data Solutions
Enterprise level workflow management, data handling and analyses
Case Study
Process Performance Qualification (PPQ): Early adoption of digital process systems puts you in control
Case Study
Enabling Novel MS-Based Methods for Characterization of Biopharmaceuticals
Case Study
Automating QC of Therapeutic Oligonucleotides in a Regulated Manufacturing Environment